Amlodipine Besylate/Benazepril Hydrochloride

苯磺酸氨氯地平/盐酸贝那普利

Report date: 2023/04/21 09:51:30

Base Information

Drug NameAmlodipine Besylate/Benazepril Hydrochloride
Drug Alias Name氨氯地平/贝那普利Amlodipine/benazeprilBenazepril Hydrochloride/Amlodipine Besylate盐酸贝那普利/苯磺酸氨氯地平氨氯地平+贝那普利 +[6] 
ClassificationSmall molecules
Mechanisms of ActionAngiotensin-converting enzyme inhibitorsVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channelAngiotensin-converting enzyme
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryUnited States
Original Approved Date1995/03/03
Country/TerritoryCanadaUnited StatesMainland China
CombinationsYes Benazepril HydrochlorideAmlodipine Besylate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesSandozChengdu Diao Pharmaceutical Group Co Ltd
Inactive CompaniesNovartis Pharma AgTeva Pharmaceuticals Usa IncFuren Pharmaceutical Group Co Ltd +[4] 
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC02N
Related LinksWikipedia